Change in the regulatory framework for zolpidem: What is the impact on the landscape of the prescription of sedative medications? The French national ZORRO study.
Marion IstvanPascal CailletMorgane RousseletMarylène GuerlaisEdouard-Jules LaforgueMarie GérardinPascale JollietFanny FeuilletCaroline Victorri-VigneauPublished in: British journal of clinical pharmacology (2021)
The regulatory change for zolpidem prescriptions reduced exposure to zolpidem among long-term users and also had a broad impact on prescriptions of other sedative medications. Switching to other medications that also present a potential risk of abuse or dependence should be carefully monitored.